Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Comparing imaging-guided and angiography-guided procedures for heart stent placement

Official title: Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)

Run by Korea University Guro Hospital · NCT06182683 · Data updated 2026-11-12

This study is testing whether using a new imaging method along with standard techniques can help people with coronary artery disease have better results when getting heart stents placed.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment700 (estimated)
SponsorKorea University Guro Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedNovember 30, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedSeptember 30, 2026
Trial IDNCT06182683 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 19 years old who are undergoing coronary stent implantation for stable angina or acute coronary syndrome.

Probably not a fit

Patients with a history of bleeding disorders, severe cardiogenic shock, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of using both optical coherence tomography (OCT) and fractional flow reserve (FFR) in guiding percutaneous coronary interventions (PCI) for patients with coronary artery disease. Participants will be randomly assigned to receive either the combined imaging approach or the conventional angiography-guided method during their stent implantation procedures. The study seeks to determine if the concurrent use of OCT and FFR leads to better clinical outcomes compared to traditional methods. By comparing these two strategies, the trial hopes to provide insights into optimizing treatment for coronary artery disease.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment outcomes for patients undergoing stent placement for coronary artery disease.

How similar studies have gone: While various studies have explored imaging-guided PCI, this specific combination of OCT and FFR has not been previously tested, making this approach novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age greater than 19 years old
2. Patients undergoing coronary stent implantation for stable angina or acute coronary syndrome
3. Patients provided on informed consent

Exclusion Criteria:

1. Individuals with a history of increased bleeding tendencies or hematologic disorders
2. Presented with refractory cardiogenic shock
3. Individuals with a history of stent thrombosis
4. Expected life expectancy of less than 1 year
5. Left ventricular ejection fraction (LVEF) ≥ 20%
6. Women who are breastfeeding, pregnant, or planning to become pregnant
7. Deemed unsuitable for participation by the investigator
8. Patients unwilling to participate in the clinical trial

Where it's running

  • Korea University Guro Hospital
    Seoul, South Korea
    Recruiting

Study contacts

  • Principal investigator: Dong Oh Kang, MD, PhD — Korea University Guro Hospital
  • Study coordinator: Dong Oh Kang, MD, PhD
  • Email: gelly9@naver.com
  • Phone: 82-2-2626-3184

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.